Department of Health and Human Services
National Institutes of Health
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Sickle Cell Disease Advisory Committee.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Information is also available on the Institute's/Center's home page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any additional information for the meeting will be posted when available.
www.nhlbi.nih.gov/meetings/index.htmName of Committee: Sickle Cell Disease Advisory Committee.
Date: October 17, 2014,
Time: 8:00 a.m. to 5:00 p.m.,
Agenda: Discussion of Programs.
Place: National Institutes of Health, 6701 Rockledge Drive, Room 9100/9104, Bethesda, MD 20892.
Contact Person: W. Keith Hoots, MD, Director, Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Suite 9030, Bethesda, MD 20892, 301-435-0080, hootswk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)
Dated: September 17, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.